Semi-Annual Statement Of Income

JCR Pharmaceuticals Co.,Ltd. - Filing #7350553

Concept 2023-04-01 to
2023-12-31
2022-04-01 to
2022-12-31
Semi-annual statement of income
Statement of income
Net sales
33,718,000,000 JPY
26,696,000,000 JPY
Cost of sales
8,423,000,000 JPY
6,899,000,000 JPY
Ordinary profit (loss)
7,388,000,000 JPY
5,291,000,000 JPY
Gross profit (loss)
25,295,000,000 JPY
19,796,000,000 JPY
Extraordinary income
0 JPY
JPY
Selling, general and administrative expenses
17,486,000,000 JPY
14,843,000,000 JPY
Extraordinary losses
18,000,000 JPY
11,000,000 JPY
Selling, general and administrative expenses
Profit (loss) before income taxes
7,371,000,000 JPY
5,280,000,000 JPY
Operating profit (loss)
7,809,000,000 JPY
4,953,000,000 JPY
Income taxes - current
2,113,000,000 JPY
233,000,000 JPY
Non-operating income
575,000,000 JPY
414,000,000 JPY
Income taxes - deferred
85,000,000 JPY
1,462,000,000 JPY
Non-operating income
Interest income
66,000,000 JPY
8,000,000 JPY
Dividend income
26,000,000 JPY
27,000,000 JPY
Income taxes
2,199,000,000 JPY
1,695,000,000 JPY
Non-operating expenses
995,000,000 JPY
76,000,000 JPY
Profit (loss)
5,172,000,000 JPY
3,584,000,000 JPY
Non-operating expenses
Interest expenses
63,000,000 JPY
33,000,000 JPY
Extraordinary income
Gain on sale of non-current assets
0 JPY
JPY
Extraordinary losses

Talk to a Data Expert

Have a question? We'll get back to you promptly.